Extrait

To demonstrate that: 1) Nepafenac Ophthalmic Suspension, 0.3% dosed once daily is not inferior to NEVANAC dosed three times daily for the prevention and treatment of ocular inflammation 14 days after cataract extraction. 2) Nepafenac Ophthalmic Suspension, 0.3% dosed once daily is superior to its vehicle dosed once daily for the prevention and treatment of ocular inflammation 14 days after cataract extraction. 3) NEVANAC dosed three times daily is superior to its vehicle dosed three times daily for the prevention and treatment of ocular inflammation 14 days after cataract extraction.

Critère d'inclusion

• The Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgery

Liens

• euctr
• ictrp
• ictrp
• euctr
• ictrp
• euctr